GDC

GD Culture Group Limited

$2.34

+$0.16 (+7.08%)Today

-$0.08 (-3.31%)After Hours

Key Statistics

Market cap10.07M

Price-Earnings ratio—

Dividend yield—

Average volume3.13M

High today$2.47

Low today$2.12

Open price$2.14

Volume1.08M

52 Week high$2478.75

52 Week low$1.85

Company Profile

Description

GD Culture Group Limited, together with its subsidiaries, engages in virtual content production business. It is involved in AI-driven digital human creation and customization. The company was formerly known as Code Chain New Continent Limited and changed its name to GD Culture Group Limited in January 2023. GD Culture Group Limited is based in Jersey City, New Jersey.

Sector

Communication Services

Industry

Electronic Gaming & Multimedia

CEO

Mr. Xiao Jian Wang

Website

gdculturegroup.com

Company Profile

Description

Sector

Communication Services

Industry

Electronic Gaming & Multimedia

CEO

Mr. Xiao Jian Wang

Website

gdculturegroup.com

GDC

Key Statistics

Company Profile

Company Profile

Recent News

Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight

APAC Green Data Center Market Poised for 33% CAGR by 2030: Digitalization and Sustainability Drive Growth

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer

High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical Activity and Drug Development | DelveInsight

Recent News

Company Profile

Recent News

Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight

APAC Green Data Center Market Poised for 33% CAGR by 2030: Digitalization and Sustainability Drive Growth

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer

High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical Activity and Drug Development | DelveInsight

Ant International Unveils Global Development Centre in Malaysia, Expanding Commitment to AI, Talent, Trust and Digital Innovation

Judge permanently bars DOT from blocking Hudson Tunnel funds

Hudson Tunnel funding restored by federal court

GDC Technology and Odeon Multicines Partner on Multi-Site Tricorne Premium LED Rollout in Spain